Last summer, Symphony financed development of three drug candidates for Bay Area biotech Exelixis (nasdaq: EXEL - news - people ), and before that, it did a similar deal with Guilford Pharmaceuticals before it was acquired by MGI Pharma (nasdaq: MOGN - news - people ).

FORBES: Biotech's Financial Lifeline

There strokes so incapacitated him that he had sometimes to write left-handed and sometimes to grasp his half-paralysed right wrist in his left hand in completing his Ninth Symphony, which opened amidst jubilation in Moscow this summer.

ECONOMIST: Alfred Schnittke